Mission Statement
The City of Hope Department of Clinical Cancer Genetics is committed to being a national leader in the advancement of cancer genetics, screening and prevention, through innovative patient care, research and education
  • description
  • description
  • description
  • description
The Department of Clinical Cancer Genetics is a multidisciplinary clinical, research and education program which focuses on recognition and assessment of people at increased risk for developing cancer because of family history or personal risk factors. 
Closing the Loop - Patient Reunion Conference 
March 21, 2009
Cancer Genetics Career Development Program
Qualifies for the NIH Loan Repayment Program
2 yr. program for MD, doctoral level nurse 
Intensive Cancer Genetics Course Announcement
Distance Learning Modules Jan. 12 - Mar. 6, 2009
On-Site Training Mar. 9 - 13, 2009
Genetics Link WebBoard
Web-based discussion forum of the City of Hope Departmant of Clinical Cancer Genetics.
Novel Targeted Treatment Study for Hereditary Breast or Ovarian Cancer (a PARP inhibitor)
Phase II multi-center studies to assess the efficacy and safety of KU-0059436
A nasal spray to reduce estrogen in women at high risk for breast cancer
Biomarkers, Breast Density, and Risk Reduction Perspectives
Cancer Prevention Trial for Postmenopausal Women
A Phase I Prevention Trial of ACTIVIN Grape Seed Extract

Developed and maintained by the Department of Biomedical Informatics at City of Hope
© 2008 All rights reserved.